Our innovative target-based technologies combine biology and
chemistry to enable efficient discovery of new compounds that
may serve as potential treatments for cancer, diabetes and
other diseases. Our chemistry-based approach is to modify
existing compounds  to discover new drug candidates. More
specifically, we use database searches to identify
pharmacophore groups to design new drug candidates.
  CANCER
  DIABETES
SONITU Pharmaceuticals is a biopharmaceutical company
utilizing innovative target-based approach  to design and
discover novel drug candidates that can be developed as novel
treatments for cancer and diabetes.
.
Our business strategy is to discover proprietary drug candidates
and develop them to obtain pre-clinical data for proof-of-concept.
For further clinical development of the selected compounds, we
will seek business relationships with other pharmaceutical
companies
SONITU PHARMACEUTICALS